Summary

The global Smart Drugs market size is predicted to grow from US$ 3661 million in 2025 to US$ 6517 million in 2032; it is expected to grow at a CAGR of 8.6% from 2026 to 2032.
Smart Drugs, a subset of broad - spectrum smart drugs, refer to over - the - counter dietary and herbal supplements designed to support and enhance human cognitive functions such as memory, focus, executive function and mental clarity. Unlike prescription cognitive enhancers, they are mainly derived from natural plant extracts, amino acids, vitamins and other nutrients, acting on the central nervous system through regulating cerebral blood flow, balancing neurotransmitter levels or providing neuroprotective nutrients, without the strong pharmacological effects of prescription drugs. It should be noted that most nootropics supplements lack rigorous large - scale clinical trials to verify their efficacy, and their effects may vary among individuals, with potential risks of adverse reactions when taken in excessive doses or combined with other substances.
Driven by the increasing pressure of academic and workplace competition, the growing demand for cognitive maintenance among the elderly and the rising awareness of brain health, the market demand for smart drugs continues to expand, with rigid demand from students, office workers and the elderly group, and incremental demand from the fields of neurological disease adjuvant therapy and sports cognitive improvement. Strict regulatory policies and unclear efficacy verification have become the main industry constraints. Business opportunities lie in strengthening clinical research to verify product efficacy and safety, developing natural, low-risk herbal supplements to meet consumer health concerns, exploring targeted solutions for specific groups, and complying with regional regulatory requirements to promote the standardized development of the industry.
LPI (LP Information)' newest research report, the “Smart Drugs Industry Forecast” looks at past sales and reviews total world Smart Drugs sales in 2025, providing a comprehensive analysis by region and market sector of projected Smart Drugs sales for 2026 through 2032. With Smart Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Smart Drugs industry.
This Insight Report provides a comprehensive analysis of the global Smart Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Smart Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Smart Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Smart Drugs and breaks down the forecast by Form, by Sales Channel, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Smart Drugs.
This report presents a comprehensive overview, market shares, and growth opportunities of Smart Drugs market by product type, application, key players and key regions and countries.
Segmentation by Form:
Capsule
Powder
Liquid
Segmentation by Source:
Natural Plant-Derived
Synthetic
Animal-Derived
Segmentation by Mechanism Of Action:
Neurotransmitter-Regulating
Cerebral Blood Flow-Improving
Antioxidant
Segmentation by Sales Channel:
Online Sales
Offline Sales
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Onnit
Qualia
Thesis
Performance Lab
Nootropics Depot
NooCube
HVMN
NeuroFuel
Gorilla Mind
Kaged
Goli Nutrition
Jocko Fuel
Bulletproof
Transparent Labs
Optimum Nutrition
Legion Athletics
Myprotein
iHerb Brands
Swanson
GNC
Vitacost Brands

ページTOPに戻る

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Smart Drugs Market Size (2021-2032)
2.1.2 Smart Drugs Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Smart Drugs by Country/Region (2021, 2025 & 2032)
2.2 Smart Drugs Segment by Form
2.2.1 Capsule
2.2.2 Powder
2.2.3 Liquid
2.2.4 Smart Drugs Market Size by Form
2.2.4.1 Smart Drugs Market Size CAGR by Form (2021 VS 2025 VS 2032)
2.2.4.2 Global Smart Drugs Market Size Market Share by Form (2021-2026)
2.3 Smart Drugs Segment by Source
2.3.1 Natural Plant-Derived
2.3.2 Synthetic
2.3.3 Animal-Derived
2.3.4 Smart Drugs Market Size by Source
2.3.4.1 Smart Drugs Market Size CAGR by Source (2021 VS 2025 VS 2032)
2.3.4.2 Global Smart Drugs Market Size Market Share by Source (2021-2026)
2.4 Smart Drugs Segment by Mechanism Of Action
2.4.1 Neurotransmitter-Regulating
2.4.2 Cerebral Blood Flow-Improving
2.4.3 Antioxidant
2.4.4 Smart Drugs Market Size by Mechanism Of Action
2.4.4.1 Smart Drugs Market Size CAGR by Mechanism Of Action (2021 VS 2025 VS 2032)
2.4.4.2 Global Smart Drugs Market Size Market Share by Mechanism Of Action (2021-2026)
2.5 Smart Drugs Segment by Sales Channel
2.5.1 Online Sales
2.5.2 Offline Sales
2.5.3 Smart Drugs Market Size by Sales Channel
2.5.3.1 Smart Drugs Market Size CAGR by Sales Channel (2021 VS 2025 VS 2032)
2.5.3.2 Global Smart Drugs Market Size Market Share by Sales Channel (2021-2026)
3 Smart Drugs Market Size by Player
3.1 Smart Drugs Market Size Market Share by Player
3.1.1 Global Smart Drugs Revenue by Player (2021-2026)
3.1.2 Global Smart Drugs Revenue Market Share by Player (2021-2026)
3.2 Global Smart Drugs Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Smart Drugs by Region
4.1 Smart Drugs Market Size by Region (2021-2026)
4.2 Global Smart Drugs Annual Revenue by Country/Region (2021-2026)
4.3 Americas Smart Drugs Market Size Growth (2021-2026)
4.4 APAC Smart Drugs Market Size Growth (2021-2026)
4.5 Europe Smart Drugs Market Size Growth (2021-2026)
4.6 Middle East & Africa Smart Drugs Market Size Growth (2021-2026)
5 Americas
5.1 Americas Smart Drugs Market Size by Country (2021-2026)
5.2 Americas Smart Drugs Market Size by Form (2021-2026)
5.3 Americas Smart Drugs Market Size by Sales Channel (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Smart Drugs Market Size by Region (2021-2026)
6.2 APAC Smart Drugs Market Size by Form (2021-2026)
6.3 APAC Smart Drugs Market Size by Sales Channel (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Smart Drugs Market Size by Country (2021-2026)
7.2 Europe Smart Drugs Market Size by Form (2021-2026)
7.3 Europe Smart Drugs Market Size by Sales Channel (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Smart Drugs by Region (2021-2026)
8.2 Middle East & Africa Smart Drugs Market Size by Form (2021-2026)
8.3 Middle East & Africa Smart Drugs Market Size by Sales Channel (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Smart Drugs Market Forecast
10.1 Global Smart Drugs Forecast by Region (2027-2032)
10.1.1 Global Smart Drugs Forecast by Region (2027-2032)
10.1.2 Americas Smart Drugs Forecast
10.1.3 APAC Smart Drugs Forecast
10.1.4 Europe Smart Drugs Forecast
10.1.5 Middle East & Africa Smart Drugs Forecast
10.2 Americas Smart Drugs Forecast by Country (2027-2032)
10.2.1 United States Market Smart Drugs Forecast
10.2.2 Canada Market Smart Drugs Forecast
10.2.3 Mexico Market Smart Drugs Forecast
10.2.4 Brazil Market Smart Drugs Forecast
10.3 APAC Smart Drugs Forecast by Region (2027-2032)
10.3.1 China Smart Drugs Market Forecast
10.3.2 Japan Market Smart Drugs Forecast
10.3.3 Korea Market Smart Drugs Forecast
10.3.4 Southeast Asia Market Smart Drugs Forecast
10.3.5 India Market Smart Drugs Forecast
10.3.6 Australia Market Smart Drugs Forecast
10.4 Europe Smart Drugs Forecast by Country (2027-2032)
10.4.1 Germany Market Smart Drugs Forecast
10.4.2 France Market Smart Drugs Forecast
10.4.3 UK Market Smart Drugs Forecast
10.4.4 Italy Market Smart Drugs Forecast
10.4.5 Russia Market Smart Drugs Forecast
10.5 Middle East & Africa Smart Drugs Forecast by Region (2027-2032)
10.5.1 Egypt Market Smart Drugs Forecast
10.5.2 South Africa Market Smart Drugs Forecast
10.5.3 Israel Market Smart Drugs Forecast
10.5.4 Turkey Market Smart Drugs Forecast
10.6 Global Smart Drugs Forecast by Form (2027-2032)
10.7 Global Smart Drugs Forecast by Sales Channel (2027-2032)
10.7.1 GCC Countries Market Smart Drugs Forecast
11 Key Players Analysis
11.1 Onnit
11.1.1 Onnit Company Information
11.1.2 Onnit Smart Drugs Product Offered
11.1.3 Onnit Smart Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Onnit Main Business Overview
11.1.5 Onnit Latest Developments
11.2 Qualia
11.2.1 Qualia Company Information
11.2.2 Qualia Smart Drugs Product Offered
11.2.3 Qualia Smart Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Qualia Main Business Overview
11.2.5 Qualia Latest Developments
11.3 Thesis
11.3.1 Thesis Company Information
11.3.2 Thesis Smart Drugs Product Offered
11.3.3 Thesis Smart Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Thesis Main Business Overview
11.3.5 Thesis Latest Developments
11.4 Performance Lab
11.4.1 Performance Lab Company Information
11.4.2 Performance Lab Smart Drugs Product Offered
11.4.3 Performance Lab Smart Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Performance Lab Main Business Overview
11.4.5 Performance Lab Latest Developments
11.5 Nootropics Depot
11.5.1 Nootropics Depot Company Information
11.5.2 Nootropics Depot Smart Drugs Product Offered
11.5.3 Nootropics Depot Smart Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Nootropics Depot Main Business Overview
11.5.5 Nootropics Depot Latest Developments
11.6 NooCube
11.6.1 NooCube Company Information
11.6.2 NooCube Smart Drugs Product Offered
11.6.3 NooCube Smart Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 NooCube Main Business Overview
11.6.5 NooCube Latest Developments
11.7 HVMN
11.7.1 HVMN Company Information
11.7.2 HVMN Smart Drugs Product Offered
11.7.3 HVMN Smart Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 HVMN Main Business Overview
11.7.5 HVMN Latest Developments
11.8 NeuroFuel
11.8.1 NeuroFuel Company Information
11.8.2 NeuroFuel Smart Drugs Product Offered
11.8.3 NeuroFuel Smart Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 NeuroFuel Main Business Overview
11.8.5 NeuroFuel Latest Developments
11.9 Gorilla Mind
11.9.1 Gorilla Mind Company Information
11.9.2 Gorilla Mind Smart Drugs Product Offered
11.9.3 Gorilla Mind Smart Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Gorilla Mind Main Business Overview
11.9.5 Gorilla Mind Latest Developments
11.10 Kaged
11.10.1 Kaged Company Information
11.10.2 Kaged Smart Drugs Product Offered
11.10.3 Kaged Smart Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Kaged Main Business Overview
11.10.5 Kaged Latest Developments
11.11 Goli Nutrition
11.11.1 Goli Nutrition Company Information
11.11.2 Goli Nutrition Smart Drugs Product Offered
11.11.3 Goli Nutrition Smart Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Goli Nutrition Main Business Overview
11.11.5 Goli Nutrition Latest Developments
11.12 Jocko Fuel
11.12.1 Jocko Fuel Company Information
11.12.2 Jocko Fuel Smart Drugs Product Offered
11.12.3 Jocko Fuel Smart Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Jocko Fuel Main Business Overview
11.12.5 Jocko Fuel Latest Developments
11.13 Bulletproof
11.13.1 Bulletproof Company Information
11.13.2 Bulletproof Smart Drugs Product Offered
11.13.3 Bulletproof Smart Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Bulletproof Main Business Overview
11.13.5 Bulletproof Latest Developments
11.14 Transparent Labs
11.14.1 Transparent Labs Company Information
11.14.2 Transparent Labs Smart Drugs Product Offered
11.14.3 Transparent Labs Smart Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Transparent Labs Main Business Overview
11.14.5 Transparent Labs Latest Developments
11.15 Optimum Nutrition
11.15.1 Optimum Nutrition Company Information
11.15.2 Optimum Nutrition Smart Drugs Product Offered
11.15.3 Optimum Nutrition Smart Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 Optimum Nutrition Main Business Overview
11.15.5 Optimum Nutrition Latest Developments
11.16 Legion Athletics
11.16.1 Legion Athletics Company Information
11.16.2 Legion Athletics Smart Drugs Product Offered
11.16.3 Legion Athletics Smart Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.16.4 Legion Athletics Main Business Overview
11.16.5 Legion Athletics Latest Developments
11.17 Myprotein
11.17.1 Myprotein Company Information
11.17.2 Myprotein Smart Drugs Product Offered
11.17.3 Myprotein Smart Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.17.4 Myprotein Main Business Overview
11.17.5 Myprotein Latest Developments
11.18 iHerb Brands
11.18.1 iHerb Brands Company Information
11.18.2 iHerb Brands Smart Drugs Product Offered
11.18.3 iHerb Brands Smart Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.18.4 iHerb Brands Main Business Overview
11.18.5 iHerb Brands Latest Developments
11.19 Swanson
11.19.1 Swanson Company Information
11.19.2 Swanson Smart Drugs Product Offered
11.19.3 Swanson Smart Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.19.4 Swanson Main Business Overview
11.19.5 Swanson Latest Developments
11.20 GNC
11.20.1 GNC Company Information
11.20.2 GNC Smart Drugs Product Offered
11.20.3 GNC Smart Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.20.4 GNC Main Business Overview
11.20.5 GNC Latest Developments
11.21 Vitacost Brands
11.21.1 Vitacost Brands Company Information
11.21.2 Vitacost Brands Smart Drugs Product Offered
11.21.3 Vitacost Brands Smart Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.21.4 Vitacost Brands Main Business Overview
11.21.5 Vitacost Brands Latest Developments
12 Research Findings and Conclusion

ページTOPに戻る

List of Tables/Graphs

List of Tables
Table 1. Smart Drugs Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Smart Drugs Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Capsule
Table 4. Major Players of Powder
Table 5. Major Players of Liquid
Table 6. Smart Drugs Market Size CAGR by Form (2021 VS 2025 VS 2032) & ($ millions)
Table 7. Global Smart Drugs Market Size by Form (2021-2026) & ($ millions)
Table 8. Global Smart Drugs Market Size Market Share by Form (2021-2026)
Table 9. Major Players of Natural Plant-Derived
Table 10. Major Players of Synthetic
Table 11. Major Players of Animal-Derived
Table 12. Smart Drugs Market Size CAGR by Source (2021 VS 2025 VS 2032) & ($ millions)
Table 13. Global Smart Drugs Market Size by Source (2021-2026) & ($ millions)
Table 14. Global Smart Drugs Market Size Market Share by Source (2021-2026)
Table 15. Major Players of Neurotransmitter-Regulating
Table 16. Major Players of Cerebral Blood Flow-Improving
Table 17. Major Players of Antioxidant
Table 18. Smart Drugs Market Size CAGR by Mechanism Of Action (2021 VS 2025 VS 2032) & ($ millions)
Table 19. Global Smart Drugs Market Size by Mechanism Of Action (2021-2026) & ($ millions)
Table 20. Global Smart Drugs Market Size Market Share by Mechanism Of Action (2021-2026)
Table 21. Smart Drugs Market Size CAGR by Sales Channel (2021 VS 2025 VS 2032) & ($ millions)
Table 22. Global Smart Drugs Market Size by Sales Channel (2021-2026) & ($ millions)
Table 23. Global Smart Drugs Market Size Market Share by Sales Channel (2021-2026)
Table 24. Global Smart Drugs Revenue by Player (2021-2026) & ($ millions)
Table 25. Global Smart Drugs Revenue Market Share by Player (2021-2026)
Table 26. Smart Drugs Key Players Head office and Products Offered
Table 27. Smart Drugs Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 28. New Products and Potential Entrants
Table 29. Mergers & Acquisitions, Expansion
Table 30. Global Smart Drugs Market Size by Region (2021-2026) & ($ millions)
Table 31. Global Smart Drugs Market Size Market Share by Region (2021-2026)
Table 32. Global Smart Drugs Revenue by Country/Region (2021-2026) & ($ millions)
Table 33. Global Smart Drugs Revenue Market Share by Country/Region (2021-2026)
Table 34. Americas Smart Drugs Market Size by Country (2021-2026) & ($ millions)
Table 35. Americas Smart Drugs Market Size Market Share by Country (2021-2026)
Table 36. Americas Smart Drugs Market Size by Form (2021-2026) & ($ millions)
Table 37. Americas Smart Drugs Market Size Market Share by Form (2021-2026)
Table 38. Americas Smart Drugs Market Size by Sales Channel (2021-2026) & ($ millions)
Table 39. Americas Smart Drugs Market Size Market Share by Sales Channel (2021-2026)
Table 40. APAC Smart Drugs Market Size by Region (2021-2026) & ($ millions)
Table 41. APAC Smart Drugs Market Size Market Share by Region (2021-2026)
Table 42. APAC Smart Drugs Market Size by Form (2021-2026) & ($ millions)
Table 43. APAC Smart Drugs Market Size by Sales Channel (2021-2026) & ($ millions)
Table 44. Europe Smart Drugs Market Size by Country (2021-2026) & ($ millions)
Table 45. Europe Smart Drugs Market Size Market Share by Country (2021-2026)
Table 46. Europe Smart Drugs Market Size by Form (2021-2026) & ($ millions)
Table 47. Europe Smart Drugs Market Size by Sales Channel (2021-2026) & ($ millions)
Table 48. Middle East & Africa Smart Drugs Market Size by Region (2021-2026) & ($ millions)
Table 49. Middle East & Africa Smart Drugs Market Size by Form (2021-2026) & ($ millions)
Table 50. Middle East & Africa Smart Drugs Market Size by Sales Channel (2021-2026) & ($ millions)
Table 51. Key Market Drivers & Growth Opportunities of Smart Drugs
Table 52. Key Market Challenges & Risks of Smart Drugs
Table 53. Key Industry Trends of Smart Drugs
Table 54. Global Smart Drugs Market Size Forecast by Region (2027-2032) & ($ millions)
Table 55. Global Smart Drugs Market Size Market Share Forecast by Region (2027-2032)
Table 56. Global Smart Drugs Market Size Forecast by Form (2027-2032) & ($ millions)
Table 57. Global Smart Drugs Market Size Forecast by Sales Channel (2027-2032) & ($ millions)
Table 58. Onnit Details, Company Type, Smart Drugs Area Served and Its Competitors
Table 59. Onnit Smart Drugs Product Offered
Table 60. Onnit Smart Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 61. Onnit Main Business
Table 62. Onnit Latest Developments
Table 63. Qualia Details, Company Type, Smart Drugs Area Served and Its Competitors
Table 64. Qualia Smart Drugs Product Offered
Table 65. Qualia Smart Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 66. Qualia Main Business
Table 67. Qualia Latest Developments
Table 68. Thesis Details, Company Type, Smart Drugs Area Served and Its Competitors
Table 69. Thesis Smart Drugs Product Offered
Table 70. Thesis Smart Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 71. Thesis Main Business
Table 72. Thesis Latest Developments
Table 73. Performance Lab Details, Company Type, Smart Drugs Area Served and Its Competitors
Table 74. Performance Lab Smart Drugs Product Offered
Table 75. Performance Lab Smart Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 76. Performance Lab Main Business
Table 77. Performance Lab Latest Developments
Table 78. Nootropics Depot Details, Company Type, Smart Drugs Area Served and Its Competitors
Table 79. Nootropics Depot Smart Drugs Product Offered
Table 80. Nootropics Depot Smart Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 81. Nootropics Depot Main Business
Table 82. Nootropics Depot Latest Developments
Table 83. NooCube Details, Company Type, Smart Drugs Area Served and Its Competitors
Table 84. NooCube Smart Drugs Product Offered
Table 85. NooCube Smart Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 86. NooCube Main Business
Table 87. NooCube Latest Developments
Table 88. HVMN Details, Company Type, Smart Drugs Area Served and Its Competitors
Table 89. HVMN Smart Drugs Product Offered
Table 90. HVMN Smart Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 91. HVMN Main Business
Table 92. HVMN Latest Developments
Table 93. NeuroFuel Details, Company Type, Smart Drugs Area Served and Its Competitors
Table 94. NeuroFuel Smart Drugs Product Offered
Table 95. NeuroFuel Smart Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 96. NeuroFuel Main Business
Table 97. NeuroFuel Latest Developments
Table 98. Gorilla Mind Details, Company Type, Smart Drugs Area Served and Its Competitors
Table 99. Gorilla Mind Smart Drugs Product Offered
Table 100. Gorilla Mind Smart Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 101. Gorilla Mind Main Business
Table 102. Gorilla Mind Latest Developments
Table 103. Kaged Details, Company Type, Smart Drugs Area Served and Its Competitors
Table 104. Kaged Smart Drugs Product Offered
Table 105. Kaged Smart Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 106. Kaged Main Business
Table 107. Kaged Latest Developments
Table 108. Goli Nutrition Details, Company Type, Smart Drugs Area Served and Its Competitors
Table 109. Goli Nutrition Smart Drugs Product Offered
Table 110. Goli Nutrition Smart Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 111. Goli Nutrition Main Business
Table 112. Goli Nutrition Latest Developments
Table 113. Jocko Fuel Details, Company Type, Smart Drugs Area Served and Its Competitors
Table 114. Jocko Fuel Smart Drugs Product Offered
Table 115. Jocko Fuel Smart Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 116. Jocko Fuel Main Business
Table 117. Jocko Fuel Latest Developments
Table 118. Bulletproof Details, Company Type, Smart Drugs Area Served and Its Competitors
Table 119. Bulletproof Smart Drugs Product Offered
Table 120. Bulletproof Smart Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 121. Bulletproof Main Business
Table 122. Bulletproof Latest Developments
Table 123. Transparent Labs Details, Company Type, Smart Drugs Area Served and Its Competitors
Table 124. Transparent Labs Smart Drugs Product Offered
Table 125. Transparent Labs Smart Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 126. Transparent Labs Main Business
Table 127. Transparent Labs Latest Developments
Table 128. Optimum Nutrition Details, Company Type, Smart Drugs Area Served and Its Competitors
Table 129. Optimum Nutrition Smart Drugs Product Offered
Table 130. Optimum Nutrition Smart Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 131. Optimum Nutrition Main Business
Table 132. Optimum Nutrition Latest Developments
Table 133. Legion Athletics Details, Company Type, Smart Drugs Area Served and Its Competitors
Table 134. Legion Athletics Smart Drugs Product Offered
Table 135. Legion Athletics Smart Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 136. Legion Athletics Main Business
Table 137. Legion Athletics Latest Developments
Table 138. Myprotein Details, Company Type, Smart Drugs Area Served and Its Competitors
Table 139. Myprotein Smart Drugs Product Offered
Table 140. Myprotein Smart Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 141. Myprotein Main Business
Table 142. Myprotein Latest Developments
Table 143. iHerb Brands Details, Company Type, Smart Drugs Area Served and Its Competitors
Table 144. iHerb Brands Smart Drugs Product Offered
Table 145. iHerb Brands Smart Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 146. iHerb Brands Main Business
Table 147. iHerb Brands Latest Developments
Table 148. Swanson Details, Company Type, Smart Drugs Area Served and Its Competitors
Table 149. Swanson Smart Drugs Product Offered
Table 150. Swanson Smart Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 151. Swanson Main Business
Table 152. Swanson Latest Developments
Table 153. GNC Details, Company Type, Smart Drugs Area Served and Its Competitors
Table 154. GNC Smart Drugs Product Offered
Table 155. GNC Smart Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 156. GNC Main Business
Table 157. GNC Latest Developments
Table 158. Vitacost Brands Details, Company Type, Smart Drugs Area Served and Its Competitors
Table 159. Vitacost Brands Smart Drugs Product Offered
Table 160. Vitacost Brands Smart Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 161. Vitacost Brands Main Business
Table 162. Vitacost Brands Latest Developments


List of Figures
Figure 1. Smart Drugs Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Smart Drugs Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Smart Drugs Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Smart Drugs Sales Market Share by Country/Region (2025)
Figure 8. Smart Drugs Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Smart Drugs Market Size Market Share by Form in 2025
Figure 10. Global Smart Drugs Market Size Market Share by Source in 2025
Figure 11. Global Smart Drugs Market Size Market Share by Mechanism Of Action in 2025
Figure 12. Smart Drugs in Online Sales
Figure 13. Global Smart Drugs Market: Online Sales (2021-2026) & ($ millions)
Figure 14. Smart Drugs in Offline Sales
Figure 15. Global Smart Drugs Market: Offline Sales (2021-2026) & ($ millions)
Figure 16. Global Smart Drugs Market Size Market Share by Sales Channel in 2025
Figure 17. Global Smart Drugs Revenue Market Share by Player in 2025
Figure 18. Global Smart Drugs Market Size Market Share by Region (2021-2026)
Figure 19. Americas Smart Drugs Market Size 2021-2026 ($ millions)
Figure 20. APAC Smart Drugs Market Size 2021-2026 ($ millions)
Figure 21. Europe Smart Drugs Market Size 2021-2026 ($ millions)
Figure 22. Middle East & Africa Smart Drugs Market Size 2021-2026 ($ millions)
Figure 23. Americas Smart Drugs Value Market Share by Country in 2025
Figure 24. United States Smart Drugs Market Size Growth 2021-2026 ($ millions)
Figure 25. Canada Smart Drugs Market Size Growth 2021-2026 ($ millions)
Figure 26. Mexico Smart Drugs Market Size Growth 2021-2026 ($ millions)
Figure 27. Brazil Smart Drugs Market Size Growth 2021-2026 ($ millions)
Figure 28. APAC Smart Drugs Market Size Market Share by Region in 2025
Figure 29. APAC Smart Drugs Market Size Market Share by Form (2021-2026)
Figure 30. APAC Smart Drugs Market Size Market Share by Sales Channel (2021-2026)
Figure 31. China Smart Drugs Market Size Growth 2021-2026 ($ millions)
Figure 32. Japan Smart Drugs Market Size Growth 2021-2026 ($ millions)
Figure 33. South Korea Smart Drugs Market Size Growth 2021-2026 ($ millions)
Figure 34. Southeast Asia Smart Drugs Market Size Growth 2021-2026 ($ millions)
Figure 35. India Smart Drugs Market Size Growth 2021-2026 ($ millions)
Figure 36. Australia Smart Drugs Market Size Growth 2021-2026 ($ millions)
Figure 37. Europe Smart Drugs Market Size Market Share by Country in 2025
Figure 38. Europe Smart Drugs Market Size Market Share by Form (2021-2026)
Figure 39. Europe Smart Drugs Market Size Market Share by Sales Channel (2021-2026)
Figure 40. Germany Smart Drugs Market Size Growth 2021-2026 ($ millions)
Figure 41. France Smart Drugs Market Size Growth 2021-2026 ($ millions)
Figure 42. UK Smart Drugs Market Size Growth 2021-2026 ($ millions)
Figure 43. Italy Smart Drugs Market Size Growth 2021-2026 ($ millions)
Figure 44. Russia Smart Drugs Market Size Growth 2021-2026 ($ millions)
Figure 45. Middle East & Africa Smart Drugs Market Size Market Share by Region (2021-2026)
Figure 46. Middle East & Africa Smart Drugs Market Size Market Share by Form (2021-2026)
Figure 47. Middle East & Africa Smart Drugs Market Size Market Share by Sales Channel (2021-2026)
Figure 48. Egypt Smart Drugs Market Size Growth 2021-2026 ($ millions)
Figure 49. South Africa Smart Drugs Market Size Growth 2021-2026 ($ millions)
Figure 50. Israel Smart Drugs Market Size Growth 2021-2026 ($ millions)
Figure 51. Turkey Smart Drugs Market Size Growth 2021-2026 ($ millions)
Figure 52. GCC Countries Smart Drugs Market Size Growth 2021-2026 ($ millions)
Figure 53. Americas Smart Drugs Market Size 2027-2032 ($ millions)
Figure 54. APAC Smart Drugs Market Size 2027-2032 ($ millions)
Figure 55. Europe Smart Drugs Market Size 2027-2032 ($ millions)
Figure 56. Middle East & Africa Smart Drugs Market Size 2027-2032 ($ millions)
Figure 57. United States Smart Drugs Market Size 2027-2032 ($ millions)
Figure 58. Canada Smart Drugs Market Size 2027-2032 ($ millions)
Figure 59. Mexico Smart Drugs Market Size 2027-2032 ($ millions)
Figure 60. Brazil Smart Drugs Market Size 2027-2032 ($ millions)
Figure 61. China Smart Drugs Market Size 2027-2032 ($ millions)
Figure 62. Japan Smart Drugs Market Size 2027-2032 ($ millions)
Figure 63. Korea Smart Drugs Market Size 2027-2032 ($ millions)
Figure 64. Southeast Asia Smart Drugs Market Size 2027-2032 ($ millions)
Figure 65. India Smart Drugs Market Size 2027-2032 ($ millions)
Figure 66. Australia Smart Drugs Market Size 2027-2032 ($ millions)
Figure 67. Germany Smart Drugs Market Size 2027-2032 ($ millions)
Figure 68. France Smart Drugs Market Size 2027-2032 ($ millions)
Figure 69. UK Smart Drugs Market Size 2027-2032 ($ millions)
Figure 70. Italy Smart Drugs Market Size 2027-2032 ($ millions)
Figure 71. Russia Smart Drugs Market Size 2027-2032 ($ millions)
Figure 72. Egypt Smart Drugs Market Size 2027-2032 ($ millions)
Figure 73. South Africa Smart Drugs Market Size 2027-2032 ($ millions)
Figure 74. Israel Smart Drugs Market Size 2027-2032 ($ millions)
Figure 75. Turkey Smart Drugs Market Size 2027-2032 ($ millions)
Figure 76. Global Smart Drugs Market Size Market Share Forecast by Form (2027-2032)
Figure 77. Global Smart Drugs Market Size Market Share Forecast by Sales Channel (2027-2032)
Figure 78. GCC Countries Smart Drugs Market Size 2027-2032 ($ millions)